These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31967783)

  • 41. Discovery and Genetic Validation of Chemotherapeutic Targets for Chagas' Disease.
    Osorio-Méndez JF; Cevallos AM
    Front Cell Infect Microbiol; 2018; 8():439. PubMed ID: 30666299
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of a Fluorescence-based Trypanosoma cruzi CYP51 Inhibition Assay for Effective Compound Triaging in Drug Discovery Programmes for Chagas Disease.
    Riley J; Brand S; Voice M; Caballero I; Calvo D; Read KD
    PLoS Negl Trop Dis; 2015 Sep; 9(9):e0004014. PubMed ID: 26394211
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structure-Guided Design and Synthesis of a Pyridazinone Series of
    Thomas MG; McGonagle K; Rowland P; Robinson DA; Dodd PG; Camino-Díaz I; Campbell L; Cantizani J; Castañeda P; Conn D; Craggs PD; Edwards D; Ferguson L; Fosberry A; Frame L; Goswami P; Hu X; Korczynska J; MacLean L; Martin J; Mutter N; Osuna-Cabello M; Paterson C; Peña I; Pinto EG; Pont C; Riley J; Shishikura Y; Simeons FRC; Stojanovski L; Thomas J; Wrobel K; Young RJ; Zmuda F; Zuccotto F; Read KD; Gilbert IH; Marco M; Miles TJ; Manzano P; De Rycker M
    J Med Chem; 2023 Aug; 66(15):10413-10431. PubMed ID: 37506194
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Appraisal of anti-protozoan activity of nitroaromatic benzenesulfonamides inhibiting carbonic anhydrases from
    Nocentini A; Osman SM; Almeida IA; Cardoso V; Alasmary FAS; AlOthman Z; Vermelho AB; Gratteri P; Supuran CT
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1164-1171. PubMed ID: 31219348
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lead selection of antiparasitic compounds from a focused library of benzenesulfonyl derivatives of heterocycles.
    Pagliero RJ; Kaiser M; Brun R; Nieto MJ; Mazzieri MR
    Bioorg Med Chem Lett; 2017 Sep; 27(17):3945-3949. PubMed ID: 28789893
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.
    Rojas Vargas JA; López AG; Pérez Y; Cos P; Froeyen M
    Parasitol Res; 2019 May; 118(5):1533-1548. PubMed ID: 30903349
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of (6 R)-2-Nitro-6-[4-(trifluoromethoxy)phenoxy]-6,7-dihydro-5 H-imidazo[2,1- b][1,3]oxazine (DNDI-8219): A New Lead for Visceral Leishmaniasis.
    Thompson AM; O'Connor PD; Marshall AJ; Blaser A; Yardley V; Maes L; Gupta S; Launay D; Braillard S; Chatelain E; Wan B; Franzblau SG; Ma Z; Cooper CB; Denny WA
    J Med Chem; 2018 Mar; 61(6):2329-2352. PubMed ID: 29461823
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Voacamine alters Leishmania ultrastructure and kills parasite by poisoning unusual bi-subunit topoisomerase IB.
    Chowdhury SR; Kumar A; Godinho JLP; De Macedo Silva ST; Zuma AA; Saha S; Kumari N; Rodrigues JCF; Sundar S; Dujardin JC; Roy S; De Souza W; Mukhopadhyay S; Majumder HK
    Biochem Pharmacol; 2017 Aug; 138():19-30. PubMed ID: 28483460
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Leishmania donovani donovani antigens recognized by kala-azar patient sera and identification of cross-reacting antigens to Chagas' disease.
    Andrade CR; Andrade PP; Wright EP
    Braz J Med Biol Res; 1988; 21(3):511-5. PubMed ID: 3147797
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 2-alkylaminoethyl-1,1-bisphosphonic acids are potent inhibitors of the enzymatic activity of Trypanosoma cruzi squalene synthase.
    Rodrígues-Poveda CA; González-Pacanowska D; Szajnman SH; Rodríguez JB
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4483-6. PubMed ID: 22585217
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High throughput screening for anti-Trypanosoma cruzi drug discovery.
    Alonso-Padilla J; Rodríguez A
    PLoS Negl Trop Dis; 2014 Dec; 8(12):e3259. PubMed ID: 25474364
    [TBL] [Abstract][Full Text] [Related]  

  • 52. VFV as a New Effective CYP51 Structure-Derived Drug Candidate for Chagas Disease and Visceral Leishmaniasis.
    Lepesheva GI; Hargrove TY; Rachakonda G; Wawrzak Z; Pomel S; Cojean S; Nde PN; Nes WD; Locuson CW; Calcutt MW; Waterman MR; Daniels JS; Loiseau PM; Villalta F
    J Infect Dis; 2015 Nov; 212(9):1439-48. PubMed ID: 25883390
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel compounds to combat trypanosomatid infections: a medicinal chemical perspective.
    González M; Cerecetto H
    Expert Opin Ther Pat; 2011 May; 21(5):699-715. PubMed ID: 21428846
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Bioactive Trypanosoma cruzi Bromodomain Inhibitor from Chemically Engineered Extracts.
    Ramallo IA; Alonso VL; Rua F; Serra E; Furlan RLE
    ACS Comb Sci; 2018 Apr; 20(4):220-228. PubMed ID: 29481050
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytotoxicity of (2,2':6',2''-terpyridine)platinum(II) complexes to Leishmania donovani, Trypanosoma cruzi, and Trypanosoma brucei.
    Lowe G; Droz AS; Vilaivan T; Weaver GW; Tweedale L; Pratt JM; Rock P; Yardley V; Croft SL
    J Med Chem; 1999 Mar; 42(6):999-1006. PubMed ID: 10090783
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular detection of Leishmania donovani, Leishmania major, and Trypanosoma species in Sergentomyia squamipleuris sand flies from a visceral leishmaniasis focus in Merti sub-County, eastern Kenya.
    Owino BO; Mwangi JM; Kiplagat S; Mwangi HN; Ingonga JM; Chebet A; Ngumbi PM; Villinger J; Masiga DK; Matoke-Muhia D
    Parasit Vectors; 2021 Jan; 14(1):53. PubMed ID: 33461609
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Trypanosoma cruzi and Leishmania infantum chagasi Infection in Wild Mammals from Maranhão State, Brazil.
    da Costa AP; Costa FB; Soares HS; Ramirez DG; Mesquita ET; Gennari SM; Marcili A
    Vector Borne Zoonotic Dis; 2015 Nov; 15(11):656-66. PubMed ID: 26501369
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Short-course combination treatment for experimental chronic Chagas disease.
    González S; Wall RJ; Thomas J; Braillard S; Brunori G; Camino Díaz I; Cantizani J; Carvalho S; Castañeda Casado P; Chatelain E; Cotillo I; Fiandor JM; Francisco AF; Grimsditch D; Keenan M; Kelly JM; Kessler A; Luise C; Lyon JJ; MacLean L; Marco M; Martin JJ; Martinez Martinez MS; Paterson C; Read KD; Santos-Villarejo A; Zuccotto F; Wyllie S; Miles TJ; De Rycker M
    Sci Transl Med; 2023 Dec; 15(726):eadg8105. PubMed ID: 38091410
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cross reactivity between Trypanosoma cruzi and Leishmania antigens in the lymphocyte blastogenesis assay.
    Carvalho EM; Reed SG; Johnson WD
    Trans R Soc Trop Med Hyg; 1987; 81(1):82-4. PubMed ID: 3127960
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Screening of Novel Inhibitors Against Leishmania donovani Calcium ion Channel to Fight Leishmaniasis.
    Kashif M; Manna PP; Akhter Y; Alaidarous M; Rub A
    Infect Disord Drug Targets; 2017; 17(2):120-129. PubMed ID: 28034363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.